← Insider buys

PRVB

Provention Bio, Inc.

No insider bought or sold Provention Bio, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

PRVB over the last year

Prices for PRVB aren't in yet.

PRVB after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

29 insider filings since 2018, newest first

PRVBSell

Sessa Capital (Master), L.P. · 10% owner

$53.3M−12.0%Apr 18
PRVBSell

Francisco Leon · Chief Scientific Officer

$767K−3.0%Feb 14
PRVBSell

Jason Hoitt · Chief Commercial Officer

$45K−100.0%Feb 14
PRVBSell

Ashleigh Palmer · Director and CEO

$765K−3.0%Feb 14
PRVBSell

Ashleigh Palmer · Director and CEO

$248K−1.0%Jan 20
PRVBSell

Francisco Leon · Chief Scientific Officer

$247K−1.0%Jan 20
PRVBSell

Sessa Capital (Master), L.P. · 10% owner

$28.2M−20.0%Jan 20
PRVBSell

Francisco Leon · Chief Scientific Officer

$1.9M−7.0%Dec 30
PRVBSell

Francisco Leon · Chief Scientific Officer

$107KDec 29
PRVBBuy

Francisco Leon · Chief Scientific Officer

$27KAug 21
PRVBBuy

Eleanor Ramos · Chief Medical Officer

$33K+4.0%Aug 20
PRVBBuy

Ashleigh Palmer · President and CEO

$36KAug 17
PRVBBuy

Francisco Leon · Chief Scientific Officer

$59KMar 20
PRVBBuy

Anthony Digiandomenico · Director

$91K+8.0%Aug 9
PRVBBuy

Ashleigh Palmer · President and CEO

$97KAug 9
PRVBBuy

Anthony Digiandomenico · Director

$110K+8.0%Jun 20
PRVBBuy

Anthony Digiandomenico · Director

$109K+9.0%Jun 18
PRVBBuy

Ashleigh Palmer · President and CEO

$43KJun 18
PRVBSell

Jeffrey Bluestone · Director

$87K−50.0%Jun 17
PRVBBuy

Anthony Digiandomenico · Director

$304K+30.0%Jun 17
PRVBBuy

Anthony Digiandomenico · Director

$39K+37.0%Dec 28
PRVBBuy

Anthony Digiandomenico · Director

$33K+47.0%Dec 27
PRVBBuy

Anthony Digiandomenico · Director

$27KNov 27
PRVBBuy

Avery W Catlin · Director

$32KNov 13
PRVBBuy

Peter A Appel · 10% owner

$3.0M+63.0%Jul 26
PRVBBuy

Ashleigh Palmer · President, CEO and 10% owner

$150K+2.0%Jul 19
PRVBBuy

Francisco Leon · Chief Scientific Officer and 10% owner

$150K+2.0%Jul 19
PRVBBuy

Andrew T Drechsler · CFO

$25KJul 19
PRVBBuy

Eleanor Ramos · Chief Medical Officer and COO

$240KJul 19

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.